Maximizing the therapeutic potential of SHP2 inhibition with rational combination strategies in tumors driven by aberrant RAS-MAPK signaling

Grace J. Lee, Carlos Stahlhut, James W. Evans, Denise Reyes, Ed Lorenzana, Neil Omaque, Tram Nguyen, Frances Zhao, Shaoling Li, Elena Koltun, Dong Lee, Zhengping Wang, Robert Nichols, Jacqueline A. M. Smith, and Mallika Singh